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Shedding of NG2 by MMP-13 Attenuates Anoikis
Nam E. Joo,1 Di Miao,2 Mercedes Bermu´dez,1 William B. Stallcup,3 and Yvonne L. Kapila1
Disruption of cell–matrix interactions can lead to anoikis—apoptosis due to loss of matrix contacts. We
previously showed that Nerve/glial antigen 2 (NG2) is a novel anoikis receptor. Specifically, overexpression of
NG2 leads to anoikis propagation, whereas its suppression leads to anoikis attenuation. Interestingly, NG2
expression decreases in late anoikis, suggesting that NG2 reduction is also critical to this process. Thus, we
hypothesized that NG2 undergoes cleavage to curtail anoikis propagation. Further, since matrix metallopro-
teinases (MMPs) cleave cell surface receptors, play a major role in modulating apoptosis, and are associated
with death receptor cleavage during apoptosis, we further hypothesized that cleavage of NG2 could be mediated
by MMPs to regulate anoikis. Indeed, anoikis conditions triggered release of the NG2 extracellular domain into
condition media during late apoptosis, and this coincided with increased MMP-13 expression. Treatment with
an MMP-13 inhibitor and MMP-13 siRNA increased anoikis, since these treatments blocked NG2 release.
Further, NG2-positive cells exhibited increased anoikis upon MMP-13 inhibition, whereas MMP-13 inhibition
did not increase anoikis in NG2-null cells, corroborating that retention of NG2 on the cell membrane is critical
for sustaining anoikis, and its cleavage for mediating anoikis attenuation. Similarly, NG2 suppression with
siRNA inhibited NG2 release and anoikis. In contrast, MMP-13 overexpression or exogenous MMP-13 reduced
anoikis by more effectively shedding NG2. In conclusion, maintenance of NG2 on the cell surface promotes
anoikis propagation, whereas its shedding by MMP-13 actions attenuates anoikis. Given that these findings are
derived in the context of periodontal ligament fibroblasts, these data have implications for periodontal in-
flammation and periodontal disease pathogenesis.
Introduction
Apoptosis or programmed cell death is a highlyregulated cellular process whose characteristic features
include cellular shrinkage, nuclear condensation, and chro-
mosomal DNA fragmentation. Apoptosis is central to many
cell and tissue processes and disease mechanisms, including
normal embryonic development and inflammation. Ex-
cessive apoptosis leads to atrophy as in neurodegenerative
diseases, whereas insufficient apoptosis contributes to can-
cer processes. Anoikis is a form of programmed cell death
mediated by loss of extracellular matrix (ECM) contacts.
The mechanisms that regulate anoikis are not fully un-
derstood. We recently identified a novel anoikis receptor,
the Nerve/glial antigen 2 (NG2) proteoglycan, yet the
mechanism by which it regulates anoikis propagation has
not been determined. The current investigation examines
this process.
NG2 is a transmembrane proteoglycan receptor that in-
teracts with ECM molecules, including type VI collagen,
and with other cell surface components, including beta-1
integrins, to mediate cell adhesion and proliferation (Burg
et al., 1997; Tillet et al., 1997; Goretzki et al., 1999; Fu-
kushi et al., 2004; Makagiansar et al., 2004; Makagiansar
et al., 2007; Chekenya et al., 2008; Stallcup and Huang,
2008; Cattaruzza et al., 2013). The cytoplasmic domain of
NG2 interacts with scaffolding proteins, such as MUPP1
and GRIP1, and with kinases, such as PKCa and ERK
(Barritt et al., 2000; Stegmu¨ller et al., 2003; Makagiansar
et al., 2004; Makagiansar et al., 2007). We previously re-
ported that anoikis signals transmitted by increased NG2
levels lead to decreases in PKCa and pFAK levels ( Joo
et al., 2008). Overexpression of NG2 decreases both PKCa
levels and phosphorylation of FAK, while suppression of
PKCa decreases FAK phosphorylation, indicating that
NG2 regulates FAK phosphorylation through PKCa in fi-
broblasts. In addition, since PKCa can phosphorylate NG2
and change its surface distribution (Makagiansar et al.,
2004), changes in PKCa levels could impact cell surface
localization and function of NG2.
We previously found that NG2 expression decreased in
late anoikis, suggesting that this NG2 reduction was also
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critical to the anoikis process. This reduction in NG2 surface
expression was accompanied by increased NG2 levels in the
extracellular media, suggesting that proteolytic processing
of NG2 was part of anoikis propagation. This became the
focus of the current study.
Many cell lines that express the full-length 300-kDa NG2
core protein—the mature and transmembranal form—also
release two truncated forms into the medium (Nishiyama
et al., 1995). One truncated 290-kDa form lacks the cyto-
plasmic domain but contains almost the entire ectodomain.
The other truncated form is a 275-kDa species that lacks the
cytoplasmic domain and at least 64 amino acids of the ec-
todomain. Mild trypsinization of B49 cells generates the
275-kDa species, suggesting that this component is pro-
duced by proteolysis of the 300-kDa form. The intact 300-
kDa form and a truncated 275-kDa form are expressed at the
surface of an NG2-transfected cell line U251NG52. Con-
version of the 300-kDa species to the 275-kDa form in
U251NG52 cells is stimulated by reagents such as phorbol
esters, which activate protein kinase C.
Phorbol esters are also known to induce expression
of matrix metalloproteinases (MMPs), such as collagenase
and stromelysin. Thus, phorbol-ester-mediated activation of
MMPs could be responsible for cleavage of the 300-kDa
NG2 core protein. Findings from other studies have sug-
gested that certain MMPs, including MMP-9, MT1-MMP,
ADAM8, and ADAM9, may be involved in NG2 processing
(Larsen et al., 2003; Asher et al., 2005). It is unclear whether
a specific MMP is associated with shedding of NG2 from the
cell surface that thereby contributes to anoikis regulation.
MMPs, zinc-dependent endopeptidases that degrade
ECM proteins, are associated with modulating different
cell behaviors, including cell proliferation, migration, and
angiogenesis. Further evidence also indicates that MMPs
regulate apoptosis. Specifically, MMPs and their inhibitors
(TIMPs) are thought to play an important role in regulating
cleavage of death and growth factor receptors in apoptosis
regulation (Ahonen et al., 2003; Tran et al., 2010). Simi-
larly, we hypothesized that proteolytic cleavage of mem-
brane-bound NG2 by MMPs may be involved in anoikis
regulation. Indeed, our findings show for the first time that
cleavage of an ECM receptor, NG2, by an MMP-mediated
process regulates anoikis. Although there are a few reports
of MMPs regulating apoptosis via cleavage of death and
growth factor receptors, to our knowledge, this is the first
report of cleavage or shedding of an ECM proteogly-
can receptor by MMPs in the regulation of anoikis. Given
that these findings are derived in the context of peri-
odontal ligament fibroblasts, these data have implications
for periodontal inflammation and periodontal disease
pathogenesis.
Materials and Methods
Cell culture
Primary human periodontal ligament fibroblasts were
obtained as described (Kapila et al., 1999). Fibroblasts were
maintained in alpha-minimal essential medium contain-
ing 10% fetal bovine serum and 1% penicillin/streptomycin/
fungizone. NG2-null mouse aortic smooth muscle cells and
wild-type control aortic smooth muscle cells (Grako et al.,
1999) were maintained in Dulbecco’s modified Eagle’s me-
dium containing 10% fetal bovine serum and 1% penicillin–
streptomycin. Conditioned media (CM) consisted of regular
cell culture media as described earlier for each cell type but
obtained from cells after treatment with the fibronectin
V+H- (anoikis) or V+H+ (control) proteins and assayed in
different experiments.
Fibronectin proteins and anoikis
Recombinant fibronectin proteins containing an alterna-
tively spliced V region (V+ ) and either an unmutated (H + )
[V+H + ] or a mutated nonfunctional, high-affinity, heparin-
binding domain (H - ) [V +H - ] were purified as described
(Kapila et al., 1999) and used to treat cells to trigger anoikis
as previously described ( Joo et al., 2008). Anoikis or control
conditions were mediated using 40 lg/mL of fibronectin
proteins, V+H - or V +H+ , respectively.
Apoptotic cell death detection by ELISA in primary
human periodontal ligament fibroblast cells
DNA fragmentation in cell lysates and supernatants was
assayed after incubation under anoikis or control conditions
using the cell-death-detection enzyme-linked immunosorbent
assay (ELISA) plus kit (Roche Molecular Biochemicals). The
ELISA, which measures cytoplasmic histone-associated
DNA fragments after induced cell death, was performed ac-
cording to the manufacturer’s instructions. Colorimetric de-
tection and quantification of the ELISA were performed on a
microplate reader (Molecular Devices).
Immunoprecipitation in primary human periodontal
ligament fibroblast cells and NG2-null mouse aortic
smooth muscle cells
Levels of NG2 proteoglycan were assessed by standard
immunoprecipitation. Cell lysates and CM were pretreated
with 0.2 U of chondroitinase ABC for 1 h at 37C and
then incubated with 50 mL of protein A-Sepharose beads
(Amersham Pharmacia Biotech) for 2 h. Supernatants were
incubated with 2 mL of B5 mouse monoclonal antibody
overnight. Samples were then pelleted, washed three times
with phosphate-buffered saline (PBS) buffer, pelleted
again, and eluted from the beads by addition of sample
buffer and boiling for 5 min. Samples were electropho-
retically resolved by standard methods on 4–12% gradient
polyacrylamide gels (Invitrogen). After electrophoresis,
gels were transferred to nitrocellulose by standard meth-
ods. The immunoblots were probed with a primary anti-
body, anti-NG2 rabbit polyclonal antibody (Chemicon),
and then incubated with a secondary anti-rabbit antibody
conjugated to peroxidase (Santa Cruz Biotechnology).
Bound antibody was detected using the ECL-plus detection
system (Pierce).
Western blotting
Samples for NG2 detection from the cellular components
were lysed using standard RIPA buffer and then pretreated
with 0.2 U of chondroitinase ABC for 1 h at 37C prior to
analysis. Samples for NG2 detection from the CM were
collected and concentrated prior to analysis. Samples were
normalized by equal volume for CM analysis or equal
protein for cell lysate analysis and then electrophoretically
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resolved using standard SDS-PAGE and western blotting.
Truncated forms of NG2 were detected with the 1657 and
1466 polyclonal antibodies (Nishiyama et al., 1991, 1995).
Intact NG2 was detected with the B5 monoclonal antibody
(Lim et al., 2007) and an NG2 polyclonal antibody (Che-
micon). Polyclonal MMP-2, MMP-9, and MMP-13 antibodies
were from Santa Cruz Biotechnology (Santa Cruz Biotech).
RNAi
Primary human periodontal ligament fibroblast cells were
transiently transfected with MMP-13 siRNA, NG2 siRNA,
or Stealth RNAi Negative Control (Santa Cruz Biotechnol-
ogy) using Lipofectamine 2000 (Invitrogen). Cells were
then treated under anoikis or control conditions in serum-
free medium for experiments. To monitor gene silencing,
cell extracts were assessed by western blotting 24, 36, and
48 h after transfection.
MMP inhibition
To explore whether MMP-13 was involved in the proteo-
lysis of the NG2 proteoglycan, cells were pretreated with 1
to 15 nM of an MMP-13 inhibitor (CAS 544678-85-5;
Calbiochem) for 2 h and then treated with the FN protein
overnight. NG2 levels in cell lysates and CM were then
assessed using standard immunoprecipitation methods with
antibodies described in the ‘‘Western blotting section’’ head-
ing. The MMP-13-specific inhibitor used in these studies
potently inhibits MMP-13 activity (IC50 = 8 nM) with ex-
pected selectivity over MMP-1, -2, -3, -7, -8, -9, -10, -12, -14,
and -16 as determined by conformational structure analysis. It
has been shown to bind to the MMP-13 catalytic domain and
act as a nonzinc-chelating inhibitor.
DNA transfection in primary human periodontal
ligament fibroblast cells
At 60–80% confluency, cells in six-well tissue culture
plates were transiently transfected with MMP-13 cDNA or
vector control using Lipofectamine 2000 (Invitrogen) for
6 h, washed, and incubated with aMEM/10%FBS for 36 h.
Cells were then treated under anoikis or control conditions
in serum-free medium for experiments. Transfection effi-
ciency was assessed by western blot of cell extracts 24, 36,
and 48 h after transfection.
Exogenous MMP-13
Recombinant human MMP-13 (Sigma) was activated
with 2 mM APMA ( p-aminophenylmercuric acetate) and
incubated at 37C for 30 min according to the manufactur-
er’s recommendations, and then dialyzed against PBS using
a membrane with a nominal molecular weight limit of
10,000 Da (Millipore). Primary human ligament fibroblast
cells were pretreated with 100 ng/mL of activated exoge-
nous MMP-13 for 2 h and then treated under anoikis or
control conditions overnight. NG2 levels in cell lysates and
CM were assessed by immunoprecipitation.
Statistical analysis
Data were analyzed by a two-way analysis of variance
and the intergroup differences were determined by Fisher’s
PLSD test. Intergroup differences were analyzed by an
unpaired Student’s t-test. p < 0.05 was considered signifi-
cant. Values are given as mean – SEM. All experiments
were performed in triplicate.
Results
Anoikis activates MMP-13 expression
and NG2 cleavage
Previously, NG2 was identified as a novel anoikis re-
ceptor, such that its upregulation led to anoikis and its
suppression rescued cells from anoikis ( Joo et al., 2008).
Interestingly, this report also demonstrated that under an-
oikis conditions, NG2 expression levels initially increased
and then decreased in cell lysates over time. However,
overexpression experiments confirmed that it was the in-
creased levels of NG2 that were driving anoikis. So, what
was the significance of the decreasing levels of NG2 in the
cell lysates over time during anoikis, when it was clear that
the high NG2 expression levels were triggering anoikis?
To answer this question, we hypothesized that NG2 might
be undergoing cell surface cleavage as a means of con-
trolling its actions during anoikis. To test this possibil-
ity, we examined whether an NG2 cleavage product was
being released into the CM of cells undergoing anoikis.
Indeed, western blot analysis of cell CM assayed after 24 h
revealed the presence of an NG2 component in the media
of cells undergoing anoikis, but not in those under con-
trol survival conditions (Fig. 1A). In fact, under anoikis
conditions, an NG2 component appeared at increasing
amounts in the CM while simultaneously disappearing
from the cell surface lysates in a time-dependent man-
ner (Fig. 1B-a). Given this finding, we reasoned that NG2
was undergoing proteolytic cleavage at the cell surface
by an MMP. Of the MMPs that are expressed at basal
levels by these periodontal ligament fibroblasts or can be
induced in the context of periodontal inflammation (Kapila
et al., 1996; Hernandez et al., 2006, 2007; Silva et al.,
2008; Herna´ndez Rı´os et al., 2009; Paula-Silva et al.,
2009; Miao et al., 2011, 2014; Ahn et al., 2014; Leppilahti
et al., 2014), MMP-13 was the only protease that exhibited
increased expression levels under anoikis conditions (Fig.
1B-b). Therefore, MMP-13 was examined over time, and
its expression also increased time dependently like the
NG2 component in the media of cells undergoing anoikis
(Fig. 1B-a). However, initial increase of MMP-13 pre-
ceded the appearance of the NG2 component in the me-
dia, which is consistent with the idea that MMP-13
undergoes increased expression and subsequent activation
by a pro-anoikis ECM, and increase and activation of
MMP-13 subsequently triggers the cleavage of NG2,
thereby mediating the release or shedding of NG2 into the
media.
As a further confirmation that NG2 was undergoing
proteolytic cleavage and shedding under anoikis conditions,
the NG2 from the CM was examined with antibodies that
specifically detect the ectodomain and cytodomain of NG2.
Western blotting experiments confirmed that the form of
NG2 that appeared in the media contained the ectodomain,
which is accessible to cell surface cleavage, but not the
cytodomain, which is intracellular and not accessible to
extracellular cleavage (Fig. 1B-c).
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To once again validate the critical role of NG2 and its
shedding in anoikis regulation, NG2 was silenced to examine
its effects on anoikis mediation. As expected, silencing NG2
with siRNA led to decreased levels of NG2 in CM and a
reduced level of DNA fragmentation (Fig. 2A, B).
Inhibiting MMP-13 activity and expression decreases
NG2 cleavage and thereby increases DNA
fragmentation
To examine whether the functional activity of MMP-13
was critical to NG2 shedding during anoikis regulation, a
chemical inhibitor of MMP-13 was examined in this con-
text. Chemical inhibition of MMP-13 activity led to a pro-
gressive drop in NG2 levels in the media, and a progressive
increase in DNA fragmentation upon treatment with in-
creasing doses of an MMP-13 inhibitor under anoikis con-
ditions (Fig. 3A, B). Thus, MMP-13 activity is required for
NG2 shedding and for limiting anoikis.
To directly examine the critical role of MMP-13 in reg-
ulating NG2 cleavage and shedding during anoikis propa-
gation, MMP-13 expression was silenced using siRNA and
examined in this mechanism. Silencing of MMP-13 con-
firmed that MMP-13 is critical to mediating the cleavage
and shedding of NG2 under anoikis conditions, since NG2
levels dropped significantly in the CM when reduced/
silenced levels of MMP-13 could no longer mediate NG2
shedding (Fig. 3C a and b). Importantly, silencing MMP-13
and inhibiting NG2 shedding led to increased levels of DNA
fragmentation under anoikis conditions (Fig. 3D). These
data corroborate that the maintenance of high levels of un-
cleaved NG2 on the cell surface is an important factor for
FIG. 2. Silencing NG2 with siRNA led to decreased levels
of NG2 in CM and a reduced level of DNA fragmentation
under anoikis conditions. (A) Western blotting of primary
human periodontal ligament fibroblast cells transfected with
(a) NG2 siRNA or control siRNA (100 pmol). Actin served
as a loading control. (b) Imunoprecipitation and western
blotting for NG2 from CM from cells treated under anoikis
conditions (fibronectin V+H- ; 40lg/mL). (B) Cell death
ELISA for DNA fragmentation assessed under anoikis
conditions for NG2-transfected, control–transfected, and
control-transfected primary human periodontal ligament fi-
broblast cells under control conditions (fibronectin V+H+ ;
40mg). Values are mean – SEM. *p< 0.05 versus control.
**p < 0.05 versus anoikis control.
FIG. 1. Anoikis conditions trigger cleavage and release of an NG2 cleavage product and increases in MMP-13 expression.
(A) (a) Primary human periodontal ligament fibroblast cell morphology and (b) cell death ELISA assessed in cells treated
under anoikis or control (Ctl) conditions (fibronectin proteins V +H - or V+H + , respectively; 40 lg/mL) for 18 h. (c)
Imunoprecipitation and western blotting of NG2 in conditioned media (CM) assessed under the same conditions as on the
top. (B) (a) Imunoprecipitation and western blotting of NG2 plus western blotting for MMP-13 in primary human peri-
odontal ligament fibroblast cell lysates and CM under the same conditions as in (A) and sampled at 2, 8, and 18 h (overnight,
O/N). Actin served as a loading control. (b) Western blotting for MMP-13, MMP-2, and MMP-9 was assessed in CM from
samples treated under the same conditions as in (A). (c) Imunoprecipitation and western blotting of NG2 under anoikis
conditions with specific ectodomain and cytodomain antibodies to NG2. Values are mean – SEM. *p< 0.05 versus control.
ELISA, enzyme-linked immunosorbent assay; MMP, matrix metalloproteinase; NG2, Nerve/glial antigen 2.
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promoting anoikis propagation, since blocking its cleavage
and release triggered higher levels of DNA fragmentation
under anoikis conditions.
MMP-13 inhibition does not alter anoikis
in NG2-null cells
To further confirm that cellular retention of uncleaved NG2
is required for anoikis propagation, NG2-null (NG2- /- ) and
NG2-positive (NG2 + / + ) cells were pretreated with an
MMP-13 inhibitor and then compared under anoikis con-
ditions. These data showed that NG2-positive cells treated
with an MMP-13 inhibitor exhibited lower levels of NG2
shedding into the CM, higher levels of NG2 cellular reten-
tion, and higher levels of DNA fragmentation under anoikis
conditions compared with controls (Fig. 4A-a and b, B-a and
b). In contrast, those not treated with an MMP-13 inhibitor
showed higher levels of NG2 shedding into the CM, lower
levels of NG2 cellular retention, and lower levels of DNA
fragmentation under anoikis conditions. It is noteworthy that
the DNA fragmentation levels are very different in these two
cell types under anoikis conditions and compared with
controls because of their NG2-null and NG2-positive status.
NG2-null cells, which do not express NG2, exhibited lower
levels of DNA fragmentation compared with the NG2 wild-
type cells under anoikis conditions. Thus, like in our pre-
vious study, NG2-null cells were resistant to anoikis ( Joo
et al., 2008). The NG2-null cells also exhibited comparable
levels of DNA fragmentation regardless of whether or not
they were treated with an MMP-13 inhibitor under anoikis
conditions. Parenthetically, the MMP-13 inhibitor limits
MMP-13 enzymatic activity but not MMP-13 expression
levels (Fig. 4A-a). Taken in aggregate, these data confirm
that inhibiting cleavage of NG2 by inhibiting MMP-13 ac-
tivity leads to retention of NG2 on the cell, which promotes
DNA fragmentation under anoikis conditions.
Overexpression of MMP-13 inhibits anoikis
To further examine the contribution of MMP-13 to NG2
cleavage and anoikis regulation, MMP-13 was over-
expressed in primary human periodontal ligament fibroblast
cells and its effects were examined in the context of anoikis.
Overexpression of MMP-13 led to increased levels of NG2
release into the CM, and decreased levels of DNA frag-
mentation under anoikis conditions (Fig. 5A, B-a and b).
Controls exhibited lower levels of NG2 release into the
media, and higher levels of DNA fragmentation.
Addition of exogenous MMP-13 to cells also led to in-
creased NG2 shedding into the CM and decreased levels of
DNA fragmentation under anoikis conditions compared with
controls (Fig. 5C, D).
Discussion
In this study, we demonstrate that MMP-13 is involved in
the shedding of NG2 to attenuate anoikis propagation in
periodontal ligament fibroblasts. Our data support the con-
cept that MMP-13 undergoes both upregulation and subse-
quent activation in CM upon anoikis to mediate this process,
since MMP-13 protein expression increases over time (Fig.
1B) and inhibition of its activity attenuates this process (Fig.
3A, B). Extracellular or pericellular activation is a common
mechanism by which MMPs undergo activation. MMP-13
can undergo extracellular activation by urokinase plasmin-
ogen activator, an enzyme that is expressed by primary
periodontal ligament cells and activated by fibronectin
fragments in these cells (Kapila et al., 1996; Zijlstra et al.,
2004). A likely mechanism driving the upregulation of
MMP-13 may stem from changes in intracellular signaling
mediated via NG2 or fibronectin fragments upon anoikis
propagation. We have shown that NG2 alters PKC and FAK
survival signaling pathways to mediate anoikis induced by
FIG. 3. An MMP-13 inhibitor and MMP-13 siRNA trigger increased DNA fragmentation due to reduced shedding of
NG2. (A) Imunoprecipitation and western blotting of NG2 in primary human periodontal ligament fibroblast cells pretreated
with exogenous 1 to 15 nM of an MMP-13-specific chemical inhibitor and then treated under anoikis (fibronectin V+H- ;
40 lg/mL) or control (Ctl; fibronectin V+H+ ; 40 lg/mL) conditions for 18 h. (B) Cell death ELISA assessed under the same
conditions as in (A). (C) Western blotting of MMP-13 (a) and imunoprecipitation and western blotting of NG2 (b) for
primary human periodontal ligament fibroblast cells transfected with MMP-13 siRNA or control transfected (200 pmol).
After transfection, cells were treated under anoikis (fibronectin protein V+H- ; 40lg/mL) or control (fibronectin V+H+ ;
40 lg/mL) conditions for 18 h. Actin was used as a loading control. Fold suppression in MMP-13 expression relative to the
actin control is indicated below the blots. (D) Cell death ELISA assessed under the same conditions as in (C). Values are
mean – SEM. *p < 0.05 versus anoikis control. **p < 0.05 versus control.
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FIG. 5. Overexpression of MMP-13
inhibits DNA fragmentation under an-
oikis conditions. (A) Western blotting
of NG2 in primary human periodontal
ligament fibroblast cells transfected
with MMP-13 cDNA or control vector
(1.5 mg) and then treated under anoikis
conditions (fibronectin protein V+H- ;
40lg/mL) for 18 h. (B) Graph of cell
death ELISA (a) of primary human
periodontal ligament fibroblast cells
transfected as in (A). Western blot (b)
confirms MMP-13 overexpression with
transfection. (C) Western blotting of
NG2 in primary human periodontal
ligament fibroblast cells pretreated with
exogenous MMP-13 (150 ng/mL) or
without (control; Ctl) and then treated
under anoikis conditions (fibronectin
protein V+H- ; 40 lg/mL). (D) Cell
death ELISA assay assessed under the
same conditions as in (C). Values are
mean –SEM. *p < 0.05 versus anoikis
control.
FIG. 4. MMP-13 inhibition did not increase
anoikis in NG2-null cells. (A) Imunoprecipitation
and western blotting of NG2 in (a) NG2-positive
(NG2 + /+ ) and (b) NG2-null (NG2 - /- ) aortic
smooth muscle cell CM and cell lysates. Cells
were pretreated with MMP-13 chemical inhibitor
(15 nM) or not treated with inhibitor (no treat.)
and then treated under anoikis (fibronectin pro-
tein V+H- ; 40lg/mL) or control (Ctl; fibro-
nectin V+H+ ; 40 lg/mL) conditions for 18 h.
(B) Cell death ELISA (a) assessed under the
same condition as in (A). Western blotting (b) for
NG2 in NG2-positive (NG2 +/+) and NG2-null
(NG2 - / - ) aortic smooth muscle cells. Values
are mean – SEM. *p < 0.05 versus control.
**p < 0.05 versus anoikis control.
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fibronectin fragments ( Joo et al., 2008). Others have shown
that fibronectin fragments stimulate MMP-13 production
and promoter activity, which involves PKC and Rac1 sig-
naling pathways (Loeser et al., 2003; Long et al., 2013).
Thus, anoikis conditions promote increased MMP-13 ex-
pression, which may be regulated by NG2 or fibronectin
fragment intracellular signaling to impact/increase MMP-13
promoter activity. Subsequent MMP-13 activation may be
carried out by extracellular urokinase plasminogen activator
activity known to be activated in periodontal ligament cells
in the context of fibronectin fragments.
Given that periodontal-disease-associated fibronectin
fragments induce anoikis and MMP expression, and sup-
press osteoblastic differentiation in periodontal ligament
fibroblasts, the present findings are relevant to periodontal
inflammation and periodontal disease pathogenesis (Kapila
et al., 1996; Huynh et al., 2002; Jee et al., 2004; Dai et al.,
2005; Ghosh et al., 2008, 2010; Joseph et al., 2010; Miao
et al., 2011). In this context, our study demonstrates that
inhibition of MMP-13 leads to significant increased NG2-
mediated cell death in periodontal ligament fibroblasts. One
possible mechanism for this induction of cell death in the
context of MMP-13 inhibition could be due to decreased
phosphorylation of FAK by retention of NG2 on the cell
membrane. As shown in our previous study of these cells,
anoikis is mediated by NG2 overexpression due to decreased
FAK signaling ( Joo et al., 2008). These findings provide
valuable information that may help when considering ther-
apeutic approaches for inflammatory diseases, like peri-
odontal disease.
Subantimicrobial or low-dose doxycline (LDD) is known
to inhibit collagenase/MMP activity. Since MMP activity,
including MMP-13 activity, increases with severity of
periodontal disease (Hernandez et al., 2006, 2007; Silva
et al., 2008; Herna´ndez Rı´os et al., 2009; Leppilahti et al.,
2014), LDD has been used to treat periodontal disease. Two
long-term studies on patients with periodontal disease
showed that daily use of LDD was effective in treating
periodontal disease when used alone or as an adjunctive
mode of therapy (Crout et al., 1996; Caton et al., 2000).
Since LDD is known to inhibit MMP-13 expression and
activity in vivo (Maher et al., 2014), LDD treatment could
compromise periodontal ligament cell survival by promot-
ing NG2 levels and anoikis propagation in these cells. Thus,
therapeutics like LDD that target a broad spectrum of col-
lagenases, including MMP-13, need to be carefully evalu-
ated to ensure that MMP inhibitory effects do not negatively
impact resident fibroblasts and induce untoward cell death.
MMPs, which have a wide range of substrates, including
various collagens and proteoglycans, are responsible for
cleavage of ECM molecules under physiological conditions.
MMPs can also cleave growth factor receptors, cytokine
receptors, notch receptors, and death receptors/ligands to
modulate apoptosis (Strand et al., 2004; Chetty et al., 2010;
Garg et al., 2010; Wadsworth et al., 2010; Alsaigh et al.,
2011; Park et al., 2011; Kim and Jung, 2012). Although
these mechanisms have been primarily studied in cancer cell
systems, there is also evidence that MMPs regulate cell
surface receptor function via cleavage in nontumorigenic
cells (Velasco-Loyden et al., 2004; Serratı` et al., 2006;
Young et al., 2010; Perng et al., 2011). We show that MMP-
13 promotes cleavage of the NG2 proteoglycan receptor,
and thereby regulates anoikis in periodontal ligament fi-
broblasts. Further, although putative substrate cleavage
consensus sequences for MMP-13 have been reported to
include aggregan, collagen II, and collagen IV, it has not
been reported whether NG2 contains a cleavage site for
MMP-13 (Deng et al., 2000). Our data are the first to sug-
gest that NG2 is a substrate for MMP-13.
In summary, the current data show that increasing re-
tention of NG2 on the membrane by MMP-13 inhibition
propagates anoikis in periodontal ligament fibroblasts. In
addition, these data show that MMP-13 secreted by fibro-
blasts is responsible for the shedding of NG2, which sub-
sequently attenuates anoikis. These mechanisms may be
important to diseases where anoikis regulation is central, as
in inflammatory diseases, including periodontal disease.
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